Interaction of α2-macroglobulin-bound thrombin with hirudin  by Pochon, François & Steinbuch, Marion
Volume 177, number 1 FEBS 1973 November 1984 
Interaction of a,-macroglobulin-bound thrombin with 
hirudin 
Franqois Pochon and Marion Steinbuch+ 
U.219 INSERM, Institut Curie - Biologie, Campus Universitaire, 91405 Orsay. and +Centre National de Transfusion 
Sanguine, 91400 Orsay, France 
Received 17 September 1984 
The human thrombin bound to cc,-macroglobulin (01~ M) in a 1: 1 stoichiometry is still able to interact with 
one of its specific inhibitors, hirudin. The dissociation constant of the complex hirudin-ol,M-bound throm- 
bin is 1 x IO-’ M, whatever the mode of thrombin binding, covalent or non-covalent. 
a,-Macroglobulin Thrombin Hirudin 
1. INTRODUCTION 2. EXPERIMENTAL 
Human cuz-macroglobulin (uzM) is a plasma 
glycoprotein of A4, 725000 composed of two 
subunits, each containing two identical chains 
linked by disulfide bridges. LYZM forms enzymati- 
tally active complexes with nearly all endoprote- 
ases. The protease binding initiates a drastic con- 
formational change of the LYZM molecule (reviews 
[ 1,2]). It has been proposed that the proteases are 
entrapped within the cvzM molecule as they lose the 
ability to react with large substrates or inhibitors 
[3], although the active site is not involved by com- 
plex formation. However, several investigations 
[4,5] have shown that the inaccessibility of the ac- 
tive center of the bound enzymes by large 
molecules is a relative rather than an absolute 
restrictive phenomenon. Several observations thus 
argue against a molecular trap hypothesis as a pro- 
ven fact [6]. 
2.1. Materials 
Human (YZM was prepared by Zn2+ affinity 
chromatography as in [lo]. Thrombin was ob- 
tained as in [l I]; the enzyme had a specific activity 
of 3200 units/mg. Hirudin was from Serva and 
had a specific activity of 1500 units/mg. 
2.2. Methods 
The enzymatic activity of thrombin was 
evaluated by the amidolytic activity of the enzyme, 
monitoring on a Cary 118 C at 25 “C the hydrolysis 
rate of the chromogenic substrate H.D.Pip.Arg. 
pNA (Kabi Kiagnostica, Sweden). 
The activity of the hirudin preparation was 
determined according to [8]. Thrombin was la- 
belled by fluorescein isothiocyanate as in [7]. 
However, we failed to observe a reaction of 
cu2M-bound thrombin with antithrombin III [7]. 
Here, we investigate such an interaction using 
hirudin, an inhibitor of thrombin, with a lower 
molecular mass and an affinity constant for the 
free enzyme [8] greater than that of AT III [9]. 
The &zM-thrombin complexes were prepared by 
adding the protease at a 1 x 10m5 M LYZM prepara- 
tion in 0.1 M NaCl, 0.05 M phosphate (pH 7.5). 
The reaction was sometimes performed in the 
presence of 0.1 M hydroxylamine [ll]. The com- 
plexes were isolated by Sephacryl S 200 filtration 
in the same buffer. 
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3. RESULTS 
The specific and stoichiometric reaction of 
hirudin (Mr 10800) with human thrombin achieves 
inactivation of the clotting activity of the protease 
as well as of its amidolytic activity on synthetic 
substrates [8]. The association rate is so fast that, 
even in the nanomolar range, the rate association 
constant cannot be accurately determined. On the 
other hand, a lOO-fold molar excess of azM is 
unable to dissociate the complex even after a 48 h 
incubation at 25°C. Indeed, no amidolytic activity 
corresponding to an eventually formed 
cYzM-thrombin complex can be detected. 
As shown in fig.1, the rate of inhibition of the 
enzymatic activity of the cuzM-bound thrombin is 
very low compared to that of the free enzyme, 
equilibrium only being reached after several hours 
of incubation, even in the presence of a large ex- 
cess of inhibitor. The inset of the figure is a plot 
of the thrombin activity as a function of hirudin 
concentration after equilibrium has been reached. 
From these data, a dissociation constant is 
calculated, Ki = 1 x lo-’ M. The value of this con- 
stant is not significantly different whatever the 
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Fig. 1. Time dependency of the inhibition of cuzM-bound 
thrombin by hirudin at pH 7.5 and 25°C. Hirudin at a 
final concentration of 5 x lo-’ M is incubated with the 
culM-thrombin complex at 1 x lo-* M. The activity of 
thrombin is tested at the indicated times. (O---O) (YZM 
covalently bound thrombin, (A---A) cv2M non- 
covalently bound thrombin. The inset is a Dixon plot of 
the residual activity of the cyzM-thrombin complex for 
different concentrations of hirudin after equilibrium has 
Fig.2. Elution profiles of a2M-bound thrombin-hirudin 
complexes. The azM-thrombin complexes are incubated 
at 25°C for 10 h with a lOO-fold molar excess of hirudin 
and chromatographed on Sephacryl S-200. The arrows 
correspond to the expected elution peak of the 
hirudin-thrombin complex. (A) and (B) are the non- 
covalent and covalent cuzM-thrombin complexes, 
respectively. The elution profiles are performed using 
the fluorescence of fluorescein-labelled thrombin 
(w); the residual activity of the bound protease is 
been reached (5 h at 25OC). also tested (A---A). 
binding mode of thrombin to CY~M, covalent or 
non-covalent. 
To exclude the possibility of the formation of an 
inactive thrombin-hirudin complex after the non- 
covalently bound thrombin has been displaced 
from its CY~M complex by hirudin, thrombin was 
first labelled by fluorescein isothiocyanate. Then 
the protease is reacted with CYZM and the complex 
incubated with a lOO-fold molar excess of hirudin 
for 5 h and the reaction mixture chromatographed 
on Sephacryl S 200 (fig.2). As expected, labelled 
thrombin is eluted associated with the a2M bulk 
using the covalent azM-thrombin complex, 
whereas only a few percent of the thrombin 
molecules are eluted as an inactive thrombin- 
hirudin conjugate, using the non-covalent 
a2M-protease complex obtained in the presence of 
hydroxylamine. Then, the observed dissociation 
constant is really that of the ternary complex LYZM- 
bound thrombin-hirudin. 
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4. DISCUSSION 
The interaction of hirudin with the azM throm- 
bin complex is very much slower than with the free 
enzyme. This difference in reaction rate probably 
did not allow authors in [12] to observe this in- 
teraction. Furthermore, a 5-fold molar excess of 
hirudin is necessary to detect a significant inhibi- 
tion. The factors causing this drastic reduction rate 
may reflect the limit of accessibilty of azM-bound 
proteases. Indeed, AT III, with a molecular mass 
nearly 6-fold greater, does not react with the con- 
jugated thrombin even in the presence of heparin 
[ 111. But other factors may be involved, for in- 
stance, the value of the affinity constant of the in- 
hibitor for the protease: that of hirudin being con- 
siderably greater than that of AT III for free 
thrombin [8,9]. Furthermore, a conformational 
modification of the surrounding of the active 
center of the protease upon a2M binding cannot be 
excluded. 
It may also be pointed out that, whatever the 
binding mode of thrombin to cuzM, covalent or 
not, the Ki for the hirudin-thrombin interaction is 
identical: the accessibility of the bound protease 
and/or its affinity constant for hirudin are not 
modified, supporting the idea that the absence of 
covalent bonds does not modify the flexibility of 
the &2M-thrombin complex and, in any case, pro- 
vides additional support for identical m2M protease 
binding sites [7]. 
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